Spots Global Cancer Trial Database for THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence
Official Title: Pilot Study of Positive Affect Training for Endocrine Therapy Medication Adherence
Study ID: NCT06388304
Interventions
Study Description
Brief Summary: The purpose of this study is to pilot and refine an online behavioral intervention based on Positive Affect Training (PAT) that aims to increase positive emotional attitudes and decrease negative emotional attitudes toward endocrine therapy (ET, i.e., anti-hormonal medication) and to increase positive affect and decrease negative affect more generally, among post-treatment breast cancer survivors who are prescribed ET to prevent recurrence of breast cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Colorado Boulder, Boulder, Colorado, United States
Contact Details
Name: Joanna Arch, PhD
Affiliation: University of Colorado, Boulder
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
